tradingkey.logo

CeriBell Inc

CBLL
View Detailed Chart
11.550USD
+0.230+2.03%
Market hours ETQuotes delayed by 15 min
422.73MMarket Cap
LossP/E TTM

CeriBell Inc

11.550
+0.230+2.03%
Intraday
1m
30m
1h
D
W
M
D

Today

+2.03%

5 Days

-10.74%

1 Month

+0.52%

6 Months

-28.22%

Year to Date

-55.37%

1 Year

-55.59%

View Detailed Chart

TradingKey Stock Score of CeriBell Inc

Currency: USD Updated: 2025-10-30

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Strong Buy. Despite a weak stock market performance, the company shows strong fundamentals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

CeriBell Inc's Score

Industry at a Glance

Industry Ranking
71 / 210
Overall Ranking
156 / 4621
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 8 analysts
Strong Buy
Current Rating
29.667
Target Price
+146.61%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

CeriBell Inc Highlights

StrengthsRisks
Ceribell, Inc. is a commercial-stage medical technology company. It is focused on transforming the diagnosis and management of patients with serious neurological conditions. It has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, highly portable and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Point-of-Care EEG enables early detection and management of suspected seizure patients, promoting precise patient care and hospital-wide efficiencies. Its Clarity AI algorithm interprets EEG in real-time, provides bedside alerts and continuous monitoring for status epilepticus. The Ceribell EEG Portal makes it easy to remotely review EEG in real-time with pre-annotated EEG insights.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 152.47% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 65.44M.
Overvalued
The company’s latest PE is -8.40, at a high 3-year percentile range.
Institutional Buying
The latest institutional holdings are 30.96M shares, increasing 10.03% quarter-over-quarter.
Held by PRFDX
Star Investor PRFDX holds 1.10K shares of this stock.

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

CeriBell Inc Info

Ceribell, Inc. is a commercial-stage medical technology company. It is focused on transforming the diagnosis and management of patients with serious neurological conditions. It has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, highly portable and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Point-of-Care EEG enables early detection and management of suspected seizure patients, promoting precise patient care and hospital-wide efficiencies. Its Clarity AI algorithm interprets EEG in real-time, provides bedside alerts and continuous monitoring for status epilepticus. The Ceribell EEG Portal makes it easy to remotely review EEG in real-time with pre-annotated EEG insights.
Ticker SymbolCBLL
CompanyCeriBell Inc
CEOMs. Xingjuan (Jane) Chao, Ph.D.
Websitehttps://ceribell.com/
KeyAI